(September 28, 2017, 4:51 PM EDT) -- WASHINGTON, D.C. — A California federal judge erred in determining that the subject matter of a patented method for detecting an antibiotic-resistant form of tuberculosis in human deoxyribonucleic acid (DNA) is patent-ineligible under Section 101 of the Patent Act, 35 U.S.C. § 101, the patent owner recently told the Federal Circuit U.S. Court of Appeals (Roche Molecular Systems Inc. v. Cepheid, No. 17-1690, Fed. Cir.)....